Immunome Inc.
IMNM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472012
In the last 90 days, Immunome Inc. insiders filed 0 open-market purchases and 7 sales; 202 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Immunome Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 153 | 1 | 183 | +31 |
| Shares | 91.4M | 180.1K | 118.3M | +27.1M (+29.7%) |
| Value | $1.07B | $2.11M | $2.54B | +$1.47B (+137.9%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (50)
Institutions that held Immunome Inc. at the end of Q4 2025 but not at the end of Q3 2025.
Sold out (19)
Institutions that held Immunome Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Opaleye Management Inc. | 3,185,000 | $37.3M |
| Toronto Dominion Bank | 1,036,056 | $12.1M |
| Renaissance Technologies LLC | 202,300 | $2.37M |
| Handelsbanken Fonder AB | 180,000 | $2.11M |
| Sphera Funds Management Ltd. | 147,200 | $1.72M |
| Gsa Capital Partners LLP | 66,420 | $778.0K |
| J. Goldman & Co LP | 61,344 | $718.3K |
| Jane Street Group, LLC | 60,708 | $710.9K |
| Virginia Retirement Systems Et Al | 58,400 | $683.9K |
| Alps Advisors Inc | 39,261 | $459.7K |
| Qube Research & Technologies Ltd | 25,217 | $295.3K |
| DRW Securities, LLC | 24,355 | $250.0K |
| Wealth Enhancement Advisory Services, LLC | 17,660 | $244.1K |
| Commonwealth Equity Services, LLC | 20,118 | $236.0K |
| Stoneridge Investment Partners LLC | 12,174 | $143.0K |
| Brighton Jones LLC | 10,513 | $123.1K |
| Quarry LP | 10,000 | $117.1K |
| BIT Capital GmbH | 5,927 | $69.4K |
| Federation des caisses Desjardins du Quebec | 352 | $4.12K |
Not filed for Q4 2025 yet (1)
Institutions that held Immunome Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| AXA Investment Managers S.A. | 180,056 | $2.11M |